Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pseudomonas Aeruginosa in Cystic Fibrosis”

98 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 98 results

Testing effectiveness (Phase 2)Study completedNCT03218917
What this trial is testing

Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis

Who this might be right for
Non-Cystic Fibrosis Bronchiectasis
Insmed Incorporated 256
Not applicableStudy completedNCT00700050
What this trial is testing

Modulation by Sex Hormones of Inflammation and Susceptibility to Pseudomonas Aeruginosa in Cystic Fibrosis Airways

Who this might be right for
Cystic Fibrosis
The Hospital for Sick Children 28
Not applicableStudy completedNCT01616862
What this trial is testing

The Carrier Rates of Pseudomonas Aeruginosa in Family Members of Children With Cystic Fibrosis

Who this might be right for
Pseudomonas AeruginosaCystic Fibrosis
Zafer Soultan 53
Large-scale testing (Phase 3)Study completedNCT01082367
What this trial is testing

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Who this might be right for
Treatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis Patients
Novartis Pharmaceuticals 50
Large-scale testing (Phase 3)Study completedNCT00112359
What this trial is testing

International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa

Who this might be right for
Cystic Fibrosis
Gilead Sciences 166
Testing effectiveness (Phase 2)Ended earlyNCT02096315
What this trial is testing

Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis.

Who this might be right for
BronchiectasisLower Respiratory Infection
Polyphor Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT00889967
What this trial is testing

Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis "ORBIT-1"

Who this might be right for
Non-Cystic Fibrosis Bronchiectasis
Aradigm Corporation 95
Post-approval studies (Phase 4)Study completedNCT01519661
What this trial is testing

Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

Who this might be right for
Pulmonary InfectionsPseudomonas Aeruginosa in Cystic Fibrosis
Novartis Pharmaceuticals 157
Not applicableLooking for participantsNCT06950892
What this trial is testing

Remote Sputum Collection in Cystic Fibrosis

Who this might be right for
Cystic FibrosisInfections
University of Pennsylvania 150
Early research (Phase 1)Looking for participantsNCT07709494
What this trial is testing

A Phase 1a/1b Study to Investigate the Safety, Tolerability, Microbiological Response, and Pharmacokinetics of Inhaled Rev-56 in Adult Healthy Volunteers and Adult Non-cystic Fibrosis Bronchiectasis (NCFB) Patients With Chronic P. Aeruginosa

Who this might be right for
Healthy ParticipantsNon-cystic Fibrosis Bronchiectasis
Revagenix, Inc. 64
Post-approval studies (Phase 4)Study completedNCT01429259
What this trial is testing

Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children

Who this might be right for
Cystic FibrosisPneumoniaPseudomonas Aeruginosa Infection
Joseph Kuti 30
Large-scale testing (Phase 3)Study completedNCT00982930
What this trial is testing

Open Label Extension to Bridging Study CTBM100C2303

Who this might be right for
Pseudomonas AeruginosaCystic Fibrosis
Novartis Pharmaceuticals 55
Not applicableStudy completedNCT01319253
What this trial is testing

A Comparator Study Evaluating Microbiological Resistance and Effects of Alternating Inhaled Antibiotic Therapies

Who this might be right for
Cystic FibrosisPseudomonas Aeruginosa
Indiana University 27
Post-approval studies (Phase 4)Study completedNCT01844778
What this trial is testing

Ease of Use and Microbial Contamination of Tobramycin Inhalation Powder (TIP) Versus Nebulised Tobramycin Inhalation Solution (TIS) and Nebulised Colistimethate (COLI)

Who this might be right for
Cystic Fibrosis
Novartis Pharmaceuticals 60
Post-approval studies (Phase 4)Ended earlyNCT01694069
What this trial is testing

Continuous Infusion Piperacillin-tazobactam for the Treatment of Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
West Virginia University 6
Testing effectiveness (Phase 2)Study completedNCT01465529
What this trial is testing

A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. Fibrosis

Who this might be right for
Cystic Fibrosis
AlgiPharma AS 26
Post-approval studies (Phase 4)UnknownNCT01044719
What this trial is testing

Duration of Antibiotics in Infective Exacerbations of Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Imperial College London 240
Testing effectiveness (Phase 2)UnknownNCT03669614
What this trial is testing

SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects

Who this might be right for
Cystic Fibrosis
Aridis Pharmaceuticals, Inc. 102
Testing effectiveness (Phase 2)Study completedNCT06159725
What this trial is testing

Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis

Who this might be right for
Persistent InfectionCystic Fibrosis
Clarametyx Biosciences, Inc. 43
Not applicableStudy completedNCT04970225
What this trial is testing

Cystic Fibrosis Blood Neutrophils

Who this might be right for
Cystic Fibrosis
Assistance Publique - Hôpitaux de Paris 47
Next Page